Patient-derived three-dimensional culture techniques model tumor heterogeneity in head and neck cancer

•Two-dimensional (2D) cell line models fail to capture tumor heterogeneity.•3D patient derived organoids capture heterogeneity and predict treatment response.•Organotypic cultures model the tumor stromal interface and invasive front.•These techniques may be used to model of critical subpopulations like partial-EMT.